GlassScriptPhysician profile
An H Pham
NPI 1609848456
$32,779.13
in general payments reported to CMS, 2019-2025
51 companies · $6,587 in 2025
The $6,587 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,163 · 2020: $2,795 · 2021: $4,268 · 2022: $4,779 · 2023: $5,124 · 2024: $6,063 · 2025: $6,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Consulting Fee: $550 · Education: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,743.25 |
| Consulting Fee | $550.00 |
| Education | $480.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,628.94 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $2,946.56 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Actelion Pharmaceuticals US, INC. | $2,633.41 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Genzyme Corporation | $2,534.06 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,698.95 | 2019-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $1,428.78 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,388.68 | 2019-2023 | Stiolto Respimat, Spiriva Respimat |
| Harmony Biosciences LLC | $1,336.65 | 2020-2025 | Wakix |
| Philips North America LLC | $1,135.02 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Mallinckrodt Hospital Products INC. | $1,106.15 | 2020-2025 | Acthar |
| Insmed, INC. | $1,007.00 | 2019-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $955.07 | 2019-2024 | Yupelri |
| United Therapeutics Corporation | $903.05 | 2020-2025 | Tyvaso, Tyvaso |
| Pfizer INC. | $868.67 | 2019-2025 | |
| Verona Pharma, INC. | $719.93 | 2025 | Ohtuvayre |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $653.61 | 2019-2024 | |
| Avadel Cns Pharmaceuticals, LLC | $563.93 | 2023-2025 | Lumryz |
| Genentech USA, INC. | $539.18 | 2019-2025 | Xolair |
| Axsome Therapeutics, INC. | $532.99 | 2022-2025 | Sunosi |
| Advanced Respiratory, INC | $468.40 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $400.00 | 2024-2025 | |
| Sunovion Pharmaceuticals INC. | $394.52 | 2019-2020 | |
| Amgen INC. | $326.90 | 2022-2025 | Tezspire |
| Sanofi-Aventis U.S. LLC | $318.92 | 2022-2025 | |
| Baxter Healthcare | $296.40 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care, Hillrom - Carnation Ambulatory Monitor |
| Viatris Specialty LLC | $224.53 | 2025 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $216.17 | 2019-2022 | |
| Electromed, INC. | $215.84 | 2021-2025 | Smartvest |
| Grifols USA, LLC | $198.58 | 2020-2025 | Prolastin-C Liquid, Xembify |
| Merck Sharp & Dohme LLC | $179.51 | 2021-2023 | Belsomra |
| Mallinckrodt Enterprises LLC | $135.94 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $132.86 | 2020-2025 | Aralast, Glassia, Hyqvia |
| Ani Pharmaceuticals, INC. | $131.19 | 2022-2025 | Purified Cortrophin Gel |
| Lilly USA, LLC | $71.57 | 2025 | Zepbound, Mounjaro |
| Shionogi INC | $64.57 | 2019 | |
| Inogen, INC. | $52.27 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Inspire Medical Systems, INC. | $47.86 | 2023-2025 | Inspire |
| Shire North American Group INC | $44.55 | 2019 | |
| Circassia INC. | $44.36 | 2019 | |
| Aytu Biopharma, INC. | $38.61 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.99 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $24.88 | 2019 | |
| Tactile Systems Technology INC | $24.65 | 2025 | Nimbl, Flexitouch Plus |
| Paratek Pharmaceuticals, INC. | $22.38 | 2022 | |
| 3b Medical, INC. | $21.39 | 2025 | Luna |
| Eisai INC. | $18.25 | 2020 | |
| Resmed Corp | $17.38 | 2019 | |
| Idorsia Pharmaceuticals US INC | $17.17 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.65 | 2019 | |
| Nabriva Therapeutics, Plc | $11.21 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw An Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.